Clinical Trial Update: Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum

View source ↗

Summary

The document summarizes a clinical trial comparing the pharmacokinetic performance of the biosimilar SB2-infliximab to the originator infliximab by measuring se…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)
• SB2 Infliximab (infliximab)

Snippet

Sponsor: The Alfred | Conditions: Inflammatory Bowel Diseases | Status: UNKNOWN